Genomic hallmarks of localized, non-indolent prostate cancer. - Test2 - elhamkhani - TriplyDB

Genomic hallmarks of localized, non-indolent prostate cancer.

Genomic hallmarks of localized, non-indolent prostate cancer.

http://www.wikidata.org/entity/Q50211176

about

MYC Deregulation in Primary Human Cancers.The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer.Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network.Molecular biomarkers to guide precision medicine in localized prostate cancer.Comparison of Pre-processing Methods for Infinium HumanMethylation450 BeadChip Array.Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.Treatment strategies for DNA repair-deficient prostate cancer.The Complex Interplay between DNA Injury and Repair in Enzymatically Induced Mutagenesis and DNA Damage in B Lymphocytes.Mitochondrial mutations drive prostate cancer aggression.Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles.Challenges and recommendations for epigenomics in precision health.Analysis of Tumor Biology to Advance Cancer Health Disparity Research.Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer.Advances in Precision Medicine: Tailoring Individualized Therapies.Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer.Extended nursing for the recovery of urinary functions and quality of life after robot-assisted laparoscopic radical prostatectomy: a randomized controlled trial.Identifying simultaneous rearrangements in cancer genomes.The Genomics of Prostate Cancer: emerging understanding with technologic advances.Loss of an Androgen-Inactivating and Isoform-Specific HSD17B4 Splice Form Enables Emergence of Castration-Resistant Prostate Cancer.Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.The long tail of oncogenic drivers in prostate cancer.Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer.MiRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation.Somatic mutations in early onset luminal breast cancer.Genomic DNA Methylation-Derived Algorithm Enables Accurate Detection of Malignant Prostate Tissues.The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study.Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.Genomic Deletion at 10q23 in Prostate Cancer: More Than PTEN Loss?Genetics and biology of prostate cancer Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects Prostate cancer susceptibility and growth linked to Y chromosome genes Frequent mutation of the untranslated region in prostate cancer Androgen-dependent alternative mRNA isoform expression in prostate cancer cells A New Strategy to Uncover the Anticancer Mechanism of Chinese Compound Formula by Integrating Systems Pharmacology and Bioinformatics ATM deficiency promotes progression of CRPC by enhancing Warburg effect Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients Genomics of adult and pediatric solid tumors

P2860

Q33836755-A1AD13B0-1DD5-41D9-A15E-29C7AD7EFFBB Q37729422-E01F3526-8E6E-413A-B9F4-2386CBD24E73 Q38637158-92AB8F75-1FC4-458A-BD25-AD3F5240787F Q38657057-D1FC2CC8-2223-480B-A045-55E9EC81EA02 Q38668635-1BC4979B-844E-4E8F-A5F7-4882054014FD Q38729924-D5CA6D5F-A593-402C-A34A-C72371292FA3 Q38836163-50D91DFB-EC42-4D61-91DE-93F17239C039 Q38855675-E36CEE3F-0344-41E2-BBCD-23A1C191E479 Q39345771-0EE361E0-2168-4BA8-87E7-9AD79DDF7014 Q41661129-40DDEC94-44F3-4576-BC43-1E7E5B849981 Q41689819-602F37AD-736F-4959-8790-E81342E38577 Q42370830-ACD675B4-94EA-4D79-B46B-4B5DF05876C1 Q46000712-EF4BA98D-1E27-4F52-9A2C-337634E17479 Q46223423-2F0EABB7-FDB0-42F0-B34A-3B5A4AD1B4B2 Q46324231-850799B2-AEDB-43F9-97CA-6B76032121D5 Q47100267-C22A4A6F-4BCE-459C-8DC4-C54C7275B687 Q47160721-58A9EC4C-3516-41CD-AFE2-21F5FDD78BE3 Q47172196-AA9C5E53-25C7-469E-8FBD-4C95B4716698 Q47202595-252A5EE9-74A1-40F8-B304-5001ED8F3B5F Q47304354-8D968409-080B-4B30-96E9-4C26B88FFB9E Q48317607-6382B1A4-27F6-4670-BD77-CF63D69B1B7A Q49817073-D156A47F-634C-4354-B8CC-5387217B7477 Q52566012-BECA9383-720D-40A9-AFEA-7CB88BD8FEB5 Q52611753-4B4C5AFB-39B0-402E-BA20-DE5763DC63DE Q52645860-4826506D-071F-4388-8000-8DE601588400 Q54977715-5A9E448C-36B8-4833-903C-39422F321FB5 Q55280468-8DD20C53-0E5E-4277-8095-E952B89B9BF6 Q55317207-CACA5CFB-26CC-4F03-93CD-412132661921 Q55397360-894A8016-A6BA-46AE-BE9E-0B3E5F9180E1 Q55398136-8B6BF5F7-21B3-4C44-9FFD-AE44122D67A9 Q55689982-4AD45982-FD7B-45EE-9F86-E4EC656BFE59 Q57106917-C3942D39-FFFA-424E-B51F-0CFFE4A7694E Q57108205-CE33166A-B06C-4227-93C9-B64F090982AF Q57114359-12906192-820A-4583-99EF-30F353B73355 Q57132120-5F9163E5-B791-4358-9CA1-CAD45CA01E2F Q57135534-97CF8018-572E-4C59-A297-28EAF54DCA15 Q57175473-F5F02F97-E06D-4986-B1CA-99E7C75F2CCA Q58542898-3ECD2AF4-C7BB-469D-9EE3-B99BAF1E45D4 Q58612336-6FD58924-52A0-40D4-948E-B5318F426ACC Q58804574-1820E6AF-F557-4167-BE2D-D88B38159A7B

P2860

Genomic hallmarks of localized, non-indolent prostate cancer.

http://www.wikidata.org/entity/Q50211176

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Genomic hallmarks of localized, non-indolent prostate cancer.

@en

Genomic hallmarks of localized, non-indolent prostate cancer.

@nl

type

label

Genomic hallmarks of localized, non-indolent prostate cancer.

@en

Genomic hallmarks of localized, non-indolent prostate cancer.

@nl

prefLabel

Genomic hallmarks of localized, non-indolent prostate cancer.

@en

Genomic hallmarks of localized, non-indolent prostate cancer.

@nl

P1433

Q50211176-2FF4F960-8C3B-49F0-886A-0BDCFCF597C0

P1476

Q50211176-FC85DD16-9CBC-4455-945E-1E9529016555

P2093

Q50211176-0405F358-D17A-4720-91BB-AF2F01CEB247

Q50211176-0ADC76FF-B6CB-47DA-BCDA-BE81EDF7981C

Q50211176-1040BF8F-8A02-4B99-B33A-2C307510B0AD

Q50211176-11B18EE7-3B6A-41AF-AAB8-5C51C2B2D642

Q50211176-1A96C618-7E73-479C-A95B-99AB27DCDA6E

Q50211176-1E5927DB-3BAB-4A29-8F77-87B71F659EBE

Q50211176-21F6BF19-D703-46A2-BCAC-39F5521D3745

Q50211176-247A149B-B9B1-4013-B90B-DD6F1825C7F1

Q50211176-294EC91A-5B69-41E9-A9C9-8A195996FA24

Q50211176-2BB426A0-C115-44B6-9174-0E8634BC4408

P2860

Q50211176-02DC632D-41F2-45E0-B137-E9946BCA07F1

Q50211176-0BBC0957-9D73-4265-BCBE-977DCE8783AC

Q50211176-0C990BAA-D4C0-4F56-9D27-65899F9B3174

Q50211176-0D1C462D-D7A5-4A2C-8632-EB6FD5695AF5

Q50211176-0E855DA9-31B4-44E0-9262-2C27214E3277

Q50211176-0EC69B03-C8D0-4673-AC06-9608D1F3D17D

Q50211176-12A65D7B-7805-49C2-86C9-5DA0F9AEBA14

Q50211176-140D85B0-89B5-478F-A62C-0CE727375D45

Q50211176-1699F7C0-0D44-4EB4-918A-B21B98969494

Q50211176-1E0E68BD-6C31-4F07-B379-1C23FB712768

P2888

Q50211176-1A1FB132-796F-4752-AF69-0D46AD312B42

P304

Q50211176-E4D0955D-832A-4E5B-9C88-351D0AE400C1

P31

Q50211176-058F71DF-0DC2-46F9-AB7A-A084E15251EF

P356

Q50211176-A8CA5B09-F189-4E50-90B9-BE7CD4F16064

P407

Q50211176-0ED2F09B-9F89-4243-A0A7-F3C0C1C8D621

P433

Q50211176-31CF6E3B-3948-445E-8F72-8F11D38A3BEE

P478

Q50211176-321F2BBD-0D57-46D4-8F75-9C37BBB9828F

P50

Q50211176-21409BDB-BA44-40F3-A87D-DACB224DFC09

Q50211176-3EC04B26-DDF1-4717-803F-01E8A8B2034D

Q50211176-52898FF5-8366-456B-9ABD-1FF221329D0F

Q50211176-56708475-0AAE-44D3-8EB9-A492B1650712

Q50211176-5B6AC4A8-B141-47F1-9BB1-74E455ED588E

Q50211176-64B5A241-0A2D-4ED1-9B7C-B4F5E4EA0296

Q50211176-786BC396-7BAC-441D-89B7-59FEFEC60392

Q50211176-A7AA047D-4E39-4D6F-A8AB-37BAC8F1C794

Q50211176-AD2EFE3F-7989-43B2-867A-DB1BD184C87D

Q50211176-C8353EA8-8B93-46C3-8265-585257E4F324

P577

Q50211176-94C73AA4-896E-46DB-A0FB-8DDBFDC659F0

P698

Q50211176-A6D2E53C-F722-426F-9EC7-8C799B991372

P356

P1433

P1476

Genomic hallmarks of localized, non-indolent prostate cancer

@en

P2093

Ada Wong

http://www.w3.org/2001/XMLSchema#string

Alain Bergeron

http://www.w3.org/2001/XMLSchema#string

Alan Dal Pra

http://www.w3.org/2001/XMLSchema#string

Alexander Murison

http://www.w3.org/2001/XMLSchema#string

Alice Meng

http://www.w3.org/2001/XMLSchema#string

Alister D'Costa

http://www.w3.org/2001/XMLSchema#string

Andre P Masella

http://www.w3.org/2001/XMLSchema#string

Bernard Tetu

http://www.w3.org/2001/XMLSchema#string

Bryan Lo

http://www.w3.org/2001/XMLSchema#string

Cenk Sahinalp

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

DELLY: structural variant discovery by integrated paired-end and split-read analysis

Mutational heterogeneity in cancer and the search for new cancer-associated genes

dbSNP: the NCBI database of genetic variation

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

The genomic complexity of primary human prostate cancer

Fast and accurate short read alignment with Burrows-Wheeler transform

Criteria for inference of chromothripsis in cancer genomes

Integrative clinical genomics of advanced prostate cancer.

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

P2888

P304

359-364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE20788

http://www.w3.org/2001/XMLSchema#string

P407

P433

7637

http://www.w3.org/2001/XMLSchema#string

P478

541

http://www.w3.org/2001/XMLSchema#string

P50

Takafumi N Yamaguchi

Robert G. Bristow

Nicholas J Harding

Julie Livingstone

Lawrence E Heisler

Alejandro Berlin

Theodorus H Van der Kwast

Housheng Hansen He

P577

2017-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28068672

http://www.w3.org/2001/XMLSchema#string